Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 49(2): e4543, 2016. graf
Artigo em Inglês | LILACS | ID: biblio-951657

RESUMO

High plasma levels of homocysteine (Hcy) promote the progression of neurodegenerative diseases. However, the mechanism by which Hcy mediates neurotoxicity has not been elucidated. We observed that upon incubation with Hcy, the viability of a neuroblastoma cell line Neuro2a declined in a dose-dependent manner, and apoptosis was induced within 48 h. The median effective concentration (EC50) of Hcy was approximately 5 mM. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) nuclear translocation and acylation has been implicated in the regulation of apoptosis. We found that nuclear translocation and acetylation of GAPDH increased in the presence of 5 mM Hcy and that higher levels of acetyltransferase p300/CBP were detected in Neuro2a cells. These findings implicate the involvement of GAPDH in the mechanism whereby Hcy induces apoptosis in neurons. This study highlights a potentially important pathway in neurodegenerative disorders, and a novel target pathway for neuroprotective therapy.


Assuntos
Animais , Coelhos , Apoptose/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Homocisteína/farmacologia , Acetilação , Acetiltransferases/análise , Fatores de Tempo , Contagem de Células , Extratos Celulares/química , Núcleo Celular/metabolismo , Sobrevivência Celular/fisiologia , Indução Enzimática , Western Blotting , Imunofluorescência , Apoptose/fisiologia , Fármacos Neuroprotetores/administração & dosagem , Linhagem Celular Tumoral , Fatores de Transcrição de p300-CBP/metabolismo , Homocisteína/administração & dosagem
2.
Indian J Biochem Biophys ; 2010 Dec; 47(6): 364-369
Artigo em Inglês | IMSEAR | ID: sea-135289

RESUMO

CREB binding protein (CBP) and E1A binding protein p300, also known as p300 are functionally related transcriptional co-activators (CoAs) and histone acetyltransferases (HATs). Some small molecules, which target HATs can activate or inhibit the p300 enzyme potently. Here, we report the binding affinities of two small molecules CTPB [N-(4-chloro- 3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide] and CTB [N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-benzamide] with p300 using docking method to obtain the insight of their interaction with p300. These small molecules bind to the enzyme, subsequently causing a structural change in the enzyme, which is responsible for the HAT activation. CTB exhibits higher binding affinity than CTPB, and their lowest docked energies are -7.72, -1.18 kcal/mol, respectively. In CTPB molecule, phenolic hydroxyl of Tyr1397 interacts with the non-polar atoms C(5E) and C(5F), and forms polar-non polar interactions. Similar interactions have also been observed in CTB. The residues Tyr1446 and Cys1438 interact with the non-pentadecyl atoms. Further, the docking study predicts a N-HO hydrogen bonding interaction between CTB and Leu1398, in which the HO contact distance is 2.06 Å. The long pentadecyl chain of CTPB reduces the formation of hydrogen bond with the p300. The H-bond interaction could be the key factor for the better activation of CTB.


Assuntos
Benzamidas/metabolismo , Benzamidas/farmacologia , Sítios de Ligação , Domínio Catalítico , Ativação Enzimática , Humanos , Ligantes , Modelos Moleculares , Fatores de Transcrição de p300-CBP/química , Fatores de Transcrição de p300-CBP/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA